Etiometry Achieves 10th FDA Clearance for Critical Care Platform

Details

Etiometry provides clinical decision support software designed for intensive care units (ICUs). The achievement of this 10th FDA clearance is particularly significant given the FDA’s recent emphasis on heightened cybersecurity requirements in medical devices. This clearance ensures that the platform's security safeguards are enhanced, protecting patient data from evolving cyber threats. The technical enhancements focus on two key modules: Data Aggregation & Visualization (DAV) and Risk Analytics Engine (RAE). For DAV, advancements include enabling institutions to standardize clinical workflows and integrating near real-time and retrospective waveform analysis. Crucially, the platform ensures seamless HL7 and FHIR compatibility for enhanced electronic medical record (EMR) data exchange. The RAE module merges FDA-cleared models for both adult and pediatric patients into a single framework, offering superior predictive accuracy based on additional data types. Furthermore, the IVCO₂ algorithm's application scope has been expanded to include patients under 29 days old. Founded in 2010, Etiometry leverages advanced analytics and AI-powered insights to help care teams detect subtle changes in patient conditions, thereby improving clinical efficiency and safety. The continued regulatory compliance demonstrated by this clearance allows hospitals to confidently deploy technology meeting the highest standards of clinical excellence and cybersecurity resilience.